Quarterly report pursuant to Section 13 or 15(d)

Shareholders??? Equity (Details Narrative)

v3.23.3
Shareholders’ Equity (Details Narrative) - USD ($)
 9 Months Ended
Aug. 04, 2023
Dec. 22, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Subsidiary, Sale of Stock [Line Items]          
Stockholders' equity, reverse stock split   reverse stock split of our common stock by a ratio of one for sixty      
Common Stock, Par or Stated Value Per Share     $ 0.001   $ 0.001
Proceeds from Issuance of Private Placement     $ 849,808  
Common Stock, Shares Authorized     4,166,666   4,166,666
Common Stock [Member] | Minimum [Member]          
Subsidiary, Sale of Stock [Line Items]          
Common Stock, Shares Authorized     4,166,666    
Common Stock [Member] | Maximum [Member]          
Subsidiary, Sale of Stock [Line Items]          
Common Stock, Shares Authorized     350,000,000    
Series E Mirroring Preferred Stock [Member]          
Subsidiary, Sale of Stock [Line Items]          
Preferred stock shares issued     404,728    
Preferred stock shares outstanding     404,728    
Series E Preferred Stock [Member]          
Subsidiary, Sale of Stock [Line Items]          
Preferred Stock, Voting Rights     The Series E Preferred Stock has super voting rights on the proposed amendment equal to 2,500 votes per share of Series E Preferred Stock.    
Security Purchase Agreement [Member] | Private Placement [Member]          
Subsidiary, Sale of Stock [Line Items]          
Number of common stock issued 404,728        
Common Stock, Par or Stated Value Per Share $ 0.01        
Proceeds from Issuance of Private Placement $ 850,000        
Security Purchase Agreement [Member] | Private Placement [Member] | Series E Mirroring Preferred Stock [Member]          
Subsidiary, Sale of Stock [Line Items]          
Number of common stock issued 404,728